Heating efficiency of PEGylated Mn–Zn ferrite nanoparticles for magnetic fluid hyperthermia

被引:0
作者
M. K. Al-Omoush
M. A. Bryleva
V. O. Dmitriev
O. E. Polozhentsev
A. V. Soldatov
机构
[1] Southern Federal University,The Smart Materials Research Institute
[2] Don State Technical University,undefined
来源
Applied Physics A | 2024年 / 130卷
关键词
Magnetic fluid hyperthermia; Manganese zinc mixed ferrite nanoparticles; Zn substitution; Magnetic properties; Specific absorption rate; Intrinsic loss power;
D O I
暂无
中图分类号
学科分类号
摘要
In this work, a series of PEGylated manganese-zinc ferrite mixed (PEG-Mn1-xZnxFe2O4) nanoparticles with varying concentrations of zinc ions (x = 0.0, 0.25, 0.4, 0.5, 0.75, 1.0) were synthesized using a solvothermal approach to investigate their physicochemical and magnetic hyperthermia properties through a range of analytical techniques, including TEM, XRF, XRD, FTIR, VSM, and magnetic hyperthermia. The PEG-Mn1-xZnxFe2O4 nanoparticles exhibited a nearly spherical shape and diameters less than 30 nm. The particle size decreased from 27 to 11.6 nm with an increasing amount of zinc (x = 0.0–0.5). The saturation magnetization (MS) value decreased with the rising Zn content, ranging from 77.8 to 30.7 emu/g. The addition of zinc led to a reduction in the specific absorption rate (SAR) of the material. This decrease in the SAR parameter was associated with a decline in the intrinsic loss power (ILP) value, varying from 0.264 nH m2/kg for MnFe2O4 to 0.037 nH m2/kg for ZnFe2O4. Consequently, these PEG-Mn1-xZnxFe2O4 nanoparticles exhibit potential as candidates for magnetic fluid hyperthermia applications.
引用
收藏
相关论文
共 126 条
[41]  
Mahmoudi M(undefined)Synthesis of ferromagnetic Fe0.6Mn0.4O nanoflowers as a new class of magnetic theranostic platform for in vivo T1–T2 dual-mode magnetic resonance imaging and magnetic hyperthermia therapy undefined undefined undefined-undefined
[42]  
Kumar CSSR(undefined)Injectable thermosensitive magnetic nanoemulsion hydrogel for multimodal-imaging-guided accurate thermoablative cancer therapy undefined undefined undefined-undefined
[43]  
Mohammad F(undefined)undefined undefined undefined undefined-undefined
[44]  
Vurro F(undefined)undefined undefined undefined undefined-undefined
[45]  
Gerosa M(undefined)undefined undefined undefined undefined-undefined
[46]  
Busato A(undefined)undefined undefined undefined undefined-undefined
[47]  
Kurian J(undefined)undefined undefined undefined undefined-undefined
[48]  
Lahiri BB(undefined)undefined undefined undefined undefined-undefined
[49]  
Mathew MJ(undefined)undefined undefined undefined undefined-undefined
[50]  
Bhardwaj A(undefined)undefined undefined undefined undefined-undefined